The salt-wasting aspect of congenital adrenal hyperplasia may be explained either by the absence of aldosterone, by the presence of a salt-excreting factor, or both.
1 Career scientist. 1 The following names and their trivial names and abbreviations are used: 3a,17a,20a-trihydroxy-5f9-pregnane (pregnanetriol); tetrahydroaldosterone = THA; pH 1 hydrolyzable aldosterone = 3 oxoconjugate (pH 1); 17a, 21 dihydroxy-pregn 1,4 diene, 3,11,20 trione When corrected for surface area, aldosterone excretion in normal children and patients with simple virilizing congenital adrenal hyperplasia is equivalent to that in adults. In children with saltwasting congenital adrenal hyperplasia, however, these levels are very low. These results support the hypothesis that aldosterone deficiency is an important factor in salt-wasting adrenal hyperplasia.
Methods
Double isotope dilution derivative assay of aldosterone and tetrahydroaldosterone Urinary free (unconjugated) aldosterone and aldosterone released by pH 1 hydrolysis (3-oxoconjugate) were measured by a modification of the double isotope dilution derivative technique of Kliman and Peterson (1, 2) . A double isotope dilution derivative method has been devised for urinary tetrahydroaldosterone glucuronide. This method and the modification of the aldosterone methods published previously (1, 2) are presented below.
Reagents. Dichlormethane, anhydrous benzene, cyclohexane, mesitylene, iso6ctane, and carbon tetrachloride were purified by passage through a bed of silica gel averaging 100 mesh in a 7-X 130-cm column and collected in 3-L portions. Ten to 20 L can be purified in 2 to 3 hours. The solvents remain reasonably free of impurities for many months at room temperature.
Dioxane, reagent grade, was purified by distillation through a fractionation column over NaOH pellets.
Pyridine was refluxed over barium oxide for 4 to 6 hours and distilled through a fractionation column. The middle fraction boiling at 1150 was collected.
Acetic anhydride was refluxed over calcium carbide for 4 to 6 hours and distilled through a fractionation column. The middle fraction boiling at 1390 was collected.
Glacial acetic acid was refluxed over an excess of chromium trioxide for 4 to 6 hours. The chromate was removed by decantation and the acetic acid distilled over fresh chromium trioxide through a fractionation column.
The middle fraction boiling at 1180 was collected.
Fresh chromium trioxide was added and the distillation repeated. (Caution: do not add chromium trioxide to hot acetic acid.) An occasional batch of reagent grade glacial acetic acid may be satisfactory if distilled through an efficient fractionation column. A brand of acetic acid distilled over chromium trioxide can also be obtained. 2 Chromium trioxide in 0.5% glacial acetic acid was prepared in the following manner: 50 mg of reagent grade chromium trioxide was dissolved in 10 ml redistilled glacial acetic acid containing 0.1 ml water. This reagent keeps for 1 to 2 weeks only. It should be discarded if it shows appreciable darkening.
Benzylhydrazide, 0.5 mg per ml methanol, was employed. The benzylhydrazide 3 is first purified by recrystallization from methanol.
Acetic anhydride-1-'4C and tritium acetic anhydride in 20% benzene (vol/vol) were obtained. 4 These were stored in a fume hood in a small ground glass stoppered ampule within a closed container containing benzene over CaCl2. It may remain reasonably free of radioactive impurities for a few weeks; however, if it is of very high specific activity (greater than 100 mc per mmole), it should be redistilled in vacuum bimonthly or weekly.
To provide a phosphor solution, we dissolved 4 g of PPO (2,5-diphenyloxazole) and 0.04 g POPOP (1,4-di-2-phenyloxazole) in benzene 5 in 1 L of reagent grade toluene. A 4% solution of Liquifluor5 in toluene may also be used.
Beta glucuronidase (Ketodase) 6 contained 5,000 U per ml.
To obtain 0.5 M acetate buffer, pH 5, we mixed 60 ml of 0.5 M acetic acid (29.4 ml glacial acetic acid diluted to 1 L with water) with 140 ml of 0.5 M sodium acetate (41.0 g sodium acetate per L of water).
Aldosterone of high specific activity (aldosterone-1,2-8H, 90 gc per ug, and aldosterone-4-J"C, 0.12 Ac per Ag)
was obtained' and purified by chromatography on paper in the solvent system benzene: methanol: water (4:2: 1) for 10 to 12 hours. Prednisone migrates with aldosterone in this system and is a convenient marker. The aldosterone was eluated and made to volume with ethanol.
Preparation of labeled tetrahydroaldosterone. The labeled aldosterone was redissolved in 0.1 ml of methanol followed by 2 10 g. The animals were killed by decapitation, and the liver was promptly removed and cut into small pieces before homogenization. All steps in the preparation were carried out at 40 C. The homogenate was centrifuged in the cold at 10,000 X g for 10 minutes. The supernatant was then centrifuged in the Spinco preparative ultracentrifuge at 100,000 X g for 1 hour. After incubation of aldosterone with the soluble rat liver enzyme preparation, the labeled steroid was extracted with 40 ml dichlormethane. The upper aqueous layer was discarded by aspiration and the solvent washed with 0.1 vol 0.1 N NaOH; after removal of the alkaline aqueous layer, the solvent was washed with 0.1 M acetic acid. After the acetic acid was discarded, the solvent was evaporated to dryness in an air stream. The residue was chromatographed on paper in the solvent system benzene: methanol: water (4: 2: 1) for 24 to 30 hours. Prednisolone may be used as a marker in this system, and in 24 hours it migrates 35 cm and tetrahydroaldosterone (3-alpha, 5-beta), 36 cm. The labeled tetrahydroaldosterone was eluted and acetylated with acetic anhydride and pyridine and chromatographed on paper in the solvent system iso6ctane: methanol: water (10: 10: 1) for 24 hours and subsequently in the cyclohexane: dioxane: methanol: water (10: 2: 10: 2) system for 12 to 14 hours. The tetrahydroaldosterone triacetate was eluted with methanol and the alcohol evaporated to dryness. The residue was dissolved in 0.2 ml methanol followed by addition of 4 ml of a solution of acetyl cholinesterase 8 (100 U per 1 ml of 0.1 M Tris buffer, pH 7.4). The acetate was hydrolyzed by incubation of this mixture at 370 for 18 hours. The free steroid was extracted with dichlormethane and the solvent washed with 0.1 N NaOH and 0.1 M acetic acid. The solvent was evaporated to dryness and the steroid again chromatographed in the benzene: methanol: water system for 20 to 24 hours.
Determination of specific actisity of labeled acetic anhydride. Labeled acetic anhydride (0.02 ml, use syringe and micropipette) and anhydrous pyridine (0.02 ml) were added to 400 ,ug of dry cortisol. The tube was closed tightly with a glass stopper. After overnight incubation at 250, 1 ml 25% ethanol in water was added to the reaction mixture. The cortisol acetate was extracted from the ethanol-water with 5 vol dichloromethane. The ethanol-water was removed by aspiration into a vacuum flask containing a strong alkali and connected to a water pump vacuum. The dichloromethane was washed twice with 1 ml water and the water removed by aspiration. A small quantity of ethanol was added to the dichloromethane, and the solvents were evaporated to dryness with an air stream in a water bath at 35 to 400 in a well-ventilated fume hood. The cortisol acetate was applied on one thin line covering the width of Whatman no. 1 paper (18-X 55-cm) and chromatographed in the solvent system cyclohexane: benzene: methanol: water (10:4:10:2) for 50 to 60 hours. The Extraction. Six to eight vol of dichloromethane was added to the urine and the mixture vigorously shaken for 15 to 20 seconds. The upper aqueous layer was discarded by aspiration. The dichloromethane extracts were washed with one-tenth vol 0.1 N NaOH. The alkaline aqueous layer was discarded and the solvent washed with one-tenth vol of 0.1 M acetic acid. After the acetic acid was discarded, a few milliliters of ethanol was added and the dichloromethane extract evaporated to dryness in a beaker placed in an air stream from a fan. The residue was dissolved in a small volume of ethanol and transferred to a 30-to 40-ml conical glass-stoppered tube and evaporated to dryness. The following liquid-liquid partition was necessary for the free aldosterone assay in adults and in all childrens' samples. The dichloromethane extracts of urinary free aldosterone must first be dissolved in a small volume of ethanol and water added to a concentration of 25% ethanol in water. This was extracted with 5 vol of cyclohexane and the cylohexane removed by aspiration. The aqueous solution was then extracted with 7 vol of dichloromethane and the aqueous layer removed by aspiration. The dichloromethane was washed with a small volume of water, and after its removal by aspiration the dichloromethane was evaporated to dryness.
Chromatography of free steroid. Approximately 0.03 ml of a saturated solution of isatin (2,3 diketoindoline) in ethanol was added to the urine extracts containing aldosterone; 40 ,ug of prednisolone was added to the urine extracts containing tetrahydroaldosterone. The residues were applied with disposable 22-cm transfer pipettes 10 to a thin 2.5-cm line on Whatman no. 1 paper and chromatographed in the solvent system benzene: methanol: water (4:2: 1). The samples containing aldosterone were chromatographed for 10 to 12 hours, and in this system aldosterone and isatin migrate 35 to 40 cm. The tetrahydroaldosterone was chromatographed for 20 to 24 hours, and tetrahydroaldosterone and prednisolone migrate 30 to 35 cm. Paper strips were cut and the aldosterone and tetrahydroaldosterone accurately located by running each strip through a Vanguard paper strip radio scanner. If marked streaking occurred in the chromatography of the free steroid, an additional chromatography was carried out before acetylation, utilizing Whatman no.
3 paper and the solvent system benzene: methanol: water (4:2: 1) for 6 hours. The samples for urinary free aldosterone were eluted and rechromatographed in the cyclohexane: dioxane: water (10:10: 2.5) system for 14 to 16 hours. In this system, aldosterone and isatin migrate 30 to 35 cm in 14 to 16 hours.
The bands of paper containing the labeled steroids were cut out and the steroids eluted with methanol in small test tubes. The methanol was dried under an air stream. The labeled steroids were transferred to ground glass stop-pered acetylation tubes (6.5 conical tubes, 13-mm diameter X 90-mm length) 11 with two washes of small volumes (1 to 2 ml) of dichloromethane, and the solvent was evaporated to dryness. Some batches of purified dichloromethane may contain a water soluble impurity that will destroy free aldosterone and tetrahydroaldosterone, and for this reason the dichloromethane must be freshly repurified by washing with liberal amounts of distilled water.
Acetylation. Before acetylation, the tubes were placed in a desiccator over CaCLa and evacuated overnight or in a vacuum oven at room temperature at pressure of 1 to 10 mm Hg for 30 to 60 minutes. After 0.02 ml anhydrous pyridine followed by 0.02 ml of tritium-labeled acetic anhydride (100 mc per mmole) was added to each tube, they were stoppered very tightly. Tritium This was used as a reverse phase system. After the spots were applied, the paper was dipped through the upper layer (nonpolar) of solvent to approximately 1.5 cm of the starting line containing the applied spots. It was not necessary to impregnate the area of the paper above the starting line. The impregnated paper was blotted and hung up to dry for 3 minutes, placed in the chromatography tank, and the lower layer (polar) added without previous equilibration. Aldosterone diacetate migrates 30 to 35 cm in 20 to 24 hours and rhodamine B, 35 to 40 cm. Satisfactory purification of the 3-oxoconjugate is achieved after this third chromatography of the diacetate of aldosterone. For the urinary free aldosterone, the following additional purification was required: After the third chromatography of the diacetate, 0.3 ml of the benzylhydrazide in methanol was added to the dried eluate and the alcohol evaporated to dryness under an air stream at 30 to 35°. The residue was chromatographed for 50 to 60 hours in the solvent system isobctane: t-butanol: methanol: water (10: 6: 10: 3). The benzylhydrazone derivative of aldosterone diacetate migrates 5 to 7 cm and the benzylhydrazide reagent, 9 to 11 cm.
Tetrahydroaldosterone triacetate. The acetylated residues were first chromatographed on paper in the solvent system iso6ctane: methanol: water (10: 10: 1) for 30 to 36 hours. A small amount of orange textile dye F-65 12 was added to each sample before chromatography. Tetrahydroaldosterone triacetate migrates with the orange dye at 35 cm. In each set of assays, tritium or '4carbon-labeled tetrahydroaldosterone triacetate was run as a separate spot to compare its migration with that of the dye marker. After chromatography, the paper strip containing the standard was run through a Vanguard paper strip scanner, and the tetrahydroaldosterone triacetate radioactivity was related to the migration of the dye marker. The bands of paper containing the tetrahydroaldosterone triacetates were cut out and the steroid eluted with methanol. The eluate was dried and the residue chromatographed in the solvent system cyclohexane: dioxane:methanol:water (10:2:10:2) for 12 to 14 hours. In this system, tetrahydroaldosterone triacetate migrates 35 cm and F-65, 38 cm. Again the labeled tetrahydroaldosterone triacetate was located by reference to the migration of the standard acetate and the dye marker. The eluates of the tetrahydroaldosterone triacetates were collected in "oxidation tubes" (20-ml ground glass stoppered round bottom tubes, 21 mm in diameter, 115 mm in length)," and 0.2 ml of freshly prepared 0.5% chromium trioxide in glacial acetic acid was added to each of the dried eluates. The tubes were rotated manually to let the solution wet all the residue and left at room temperature for 15 to 20 minutes. One ml of distilled water was added and the steroid extracted with 10 ml dichloromethane. The dichloromethane was washed with 1 ml of distilled water and the water discarded by aspiration. After again removing the aqueous layer, we evaporated the solvent to dryness and chromatographed each sample in the solvent system cyclohexane: benzene: methanol: water (100: 25:100:10) for 12 to The precision of measurement was + 2% for`4C on the upper channel, 0.5% for 14C on the lower channel, and 3% for tritium. For optimal precision, the 'H/14C ratio should be 0.1 to 100. The efficiency for tritium was 33% and for "'carbon, 65% (model 314E) (5).
The steroid concentration was calculated as follows:
Hi/H. X C/S0 X mol wt/1,000 X (24 hour urine volume/ volume urine extracted) = (micrograms aldosterone or tetrahydroaldosterone per 24-hour urine volume), where Hi= counts per minute 14C added to the sample; H.= counts per minute 14C in the counting vial; C = counts per minute 'H in the counting vial; S = specific activity steroid diacetate (counts per minute 'H per millimicromole); and mol wt = molecular weight of free steroid.
If the weight of added aldosterone (Hi) is very small, it need not be included in the calculations (5).
Specificity. The specificity of the method was evaluated by the constant specific activity of the aldosterone in the two final successive steps. For aldosterone, this was assessed by the 'H/flC ratio after the chromatography of aldosterone diacetate in the reverse phase system mesitylene: methanol: water (3: 2: 1) (ratio A, Table I ), and after chromatography of the derivative, aldosterone diacetate benzylhydrazone in the solvent system isobctane: t-butanol: methanol: water (10: 6: 10:
3) (ratio B, Table I ).
For tetrahydroaldosterone the constancy of specific activity was evaluated by the 'H/'4C'ratio in the two final successive purification steps, i.e., after the second chromatography of the oxidation product of tetrahydroaldosterone in the solvent system cyclohexane: dioxane: methanol: water (10: 2:10:1) (ratio A, Table II), and after the residue from this chromatography was treated with benzylhydrazide and chromatographed in the system cyclohexane: benzene: methanol: water (10: 2.5: 10: 1) (ratio B, Table II ). The benzylhydrazide does not react with the oxidized product of tetrahydroaldosterone, but it may react with impurities.
The specificity of the aldosterone method was also indicated by the identical results on four urine samples when two different derivatives were formed. The results were the same whether aldosterone was assayed by forming the oxidation product of aldosterone diacetate, as indicated by Kliman and Peterson (1) , or by forming the aldosterone diacetate benzylhydrazone derivative (Table III) .
Although no children who had been adrenalectomized The over-all recovery of added tritiated or 'C-labeled aldosterone ranged from 7 to 12% for the free aldosterone assay, 7 to 16% for the 3-oxoconjugate, and 7 to 10% for tetrahydroaldosterone.
Precision of the assay for aldosterone is indicated in the duplicate determinations on nine samples (Table IV) .
The sensitivity of the method is limited by the specific activity of the radioactive acetic anhydride, and the accuracy depends on the purity of the added labeled aldosterone and the isolated aldosterone. When using 'H-labeled acetic anhydride, 100 mc per mmole, assuming a 10% recovery, and demanding 100% more counts per minute than background, this method is sensitive to 2.5 msug of aldosterone. Normal values of urinary aldosterone excretion in adults were: 3-oxoconjugate, 5 to 20 ,ug per day; tetrahydroaldosterone, 15 to 80 leg per day; and free aldosterone, 0.05 to 0.2 /Ag per day. Plasma cortisol was determined by the method of Peterson (7) . Urinary 17-hydroxycorticoids were assayed by the method of Peterson and associates (8) . Urinary 17-ketosteroids were assayed by the method of Peterson (9) . Serum and urinary sodium and potassium were determined by flame photometry. Urinary pregnanetriol was assayed by a new isotope dilution method to be published. The normal values of urinary pregnanetriol when this method was used were: prepubescent children, 0 to 0.2 mg per 24 hours; and adolescents and adults, 0.05 to 0.2 mg per 24 hours. 
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c UntreatedJi higher than normal levels of aldosterone when corrected for surface area, whereas none of the five treated patients exceeded the normal range. Excretion of aldosterone metabolites (3-oxoconjugate and tetrahydroaldosterone glucuronoside) was lower than normal in 11 children with the salt-losing form of adrenal hyperplasia. The exceptions to this were three patients (K.P., A.K., and T.P., Table V ) who had only one episode of mild hyponatremia and hyperkalemia, and whose subsequent clinical picture did not indicate repetition of this difficulty despite the absence of mineralocorticoid treatment.
* Salt losers ---------------------------------------
Two of the patients (D. I. and N.J., Table VI ), who were clinically classified as suffering from simple virilizing congenital adrenal hyperplasia excreted very low levels of aldosterone (both 3-oxoconjugated and tetrahydroaldosterone glucuronide). One of these patients (D.I.) is the 7f-year-old sibling of S.I. (no. 5), whose aldosterone excretion is normal. Clinically, D.I. is a salt craver, whereas S.I. is not (see Table VI ).
Sodium restriction experiments
A) Patients with salt-losing congenital adrenal hyperplasia. Seven patients with salt-losing adrenal hyperplasia were subjected to sodium restriction. A typical study of the sodium intake, urinary sodium, serum electrolytes, weight, and aldosterone excretion or secretion rates is illustrated by Figure 4 .
The four salt losers with the most frequent episodes of crises (T.F., D.C., S.D., and S.S., Table  V ) had low base-line aldosterone levels, and their aldosterone excretion did not increase significantly with salt restriction. The three salt losers with less severe disease clinically (K.P., N.B., and T.P., Table V ) started with normal levels of urinary aldosterone but showed no increase with sodium restriction. One of these patients (T.P.) did not demonstrate an increased aldosterone excretion on the third day of sodium restriction but did show an increase in the aldosterone turnover rate on the fourth day.
B) Patients with simple virilizing adrenal hyperplasia. Three patients with simple virilizing adrenal hyperplasia, (T.B., P.G., and P.S., Table   VI ) showed a more than threefold increase in their normal base-line urinary aldosterone (Figure 5) . Two of these patients (T.B. and P.S.) had not been treated with glucocorticoid. These three patients, in contrast to the salt losers, showed a marked decrease in urinary sodium output with sodium restriction. o ULntreatedlsimPle virilizing adrenal hyperplasia ----11 Newborn untreated salt loser. A newborn virilized female sibling of a patient with salt-losing congenital adrenal hyperplasia (A.C., Table V) was studied in the first and second days of life before she manifested any electrolyte disorder. At this time the aldosterone turnover rate was 3. Table VI ).
Urinary excretion of metabolites of aldosterone. The metabolism of aldosterone in seven children with various disorders was studied by administering tritiated aldosterone (ring-labeled in the 1,2 position) and measuring the per cent of the administered aldosterone excreted as the free, the 3-oxoconjugate, and the tetrahydroaldosterone glucuronide. Ring-labeled aldosterone-4-14C and ring-labeled tetrahydroaldosterone -4-14C were added to the urine to detect procedural losses. Results indicate that the ratio of metabolites of aldosterone in the urine of children of various ages and with various diseases was similar to that of adults (10) ( Table VIII) . The ratio of urinary metabolites of aldosterone remained constant in three patients on two separate studies. This would indicate that changes in urinary metabolite excretion of aldosterone in the same subjects reflect alterations in aldosterone production (11-13).
Addison's disease. Three patients with Addison's disease excreted no metabolites of aldosterone. The youngest patient (J.Y., Table VI) did not increase his turnover rate of aldosterone even when his serum Na was 115 mEq per L.
Discussion
The results indicate that aldosterone production is impaired in salt-losing adrenal hyperplasia, even under the stress of sodium restriction and hyponatremia, whereas it is not impaired in the simple virilizing type of adrenal hyperplasia. The level of aldosterone excretion in a large group of normal children is comparable to that of the adult when values are corrected for surface area. The ratio of metabolites of aldosterone in the urine of children is similar to that in the adult.
The normal aldosterone production in one infant with salt-losing adrenal hyperplasia before salt-wasting manifestations and the subsequent fall in aldosterone production when salt-wasting symptoms required treatment indicate an early capacity to produce aldosterone that is lost. The decrease in aldosterone production cannot be attributed to atrophy of the adrenal due to steroid treatment, since infants with simple virilizing adrenal hyperplasia on similar steroidal treatment retain the capacity to produce normal amounts of aldosterone and to increase aldosterone with salt restriction. The maintenance dosage of steroids used in treatment would not be sufficient to cause significant sodium retention. It would require a dose of 1 to 2 mg of 1 1-deoxycorticosterone (DOC) or 25 to 50 mg of hydrocortisone or 100 mg of prednisone or prednisolone to cause the same mineralocorticoid activity of 50 Mug of aldosterone. Under conditions of sodium restriction the requirements would be 3 to 4 times higher. Thus, the maintenance doses of glucocorticoid used in these subjects should not decrease aldosterone production significantly (14, 15) .
The low level of aldosterone excretion in the patient with the hypertensive form of congenital adrenal hyperplasia confirms the results of Kowarski and co-workers (16) and is in disagreement with the report by Holub and Barlow (17) .
The data presented support the hypothesis that the salt-losing aspect of adrenal hyperplasia is caused by hypoaldosteronism. The inability to produce adequate amounts of aldosterone is probably due to a severe defect in 21-hydroxylation. This increased severity of the enzymic defect in salt-losing congenital adrenal hyperplasia when compared to the simple virilizing adrenal hyperplasia has been suggested by the lower levels of tetrahydrocortisone observed in salt losers (18, 19) .
The various arguments that have been advanced for the importance of the salt-excreting factor (20) in causing salt wasting may be enumerated as follows.
1) The early data indicate normal to supernormal aldosterone levels in salt losers. Von Prader, Spahr, and Neher (21) Jailer, Ulich, and Lieberman (24) in 1959 found the aldosterone secretion rate by the isotope dilu-tion assay to be normal in two salt losers and elevated in two out of three simple virilizers. They also reported no defect in cortisol secretion in the salt losers in whom ACTH produced sodium loss and adrenal crisis.
Rosemberg and co-workers (25) described a child with salt-losing adrenal hyperplasia studied at 18 months of age and again at 4j years who excreted normal to high levels of aldosterone (23.8 jug per day).
The investigators thus far cited concluded that there was no aldosterone deficiency in the saltlosing form of adrenal hyperplasia and that a saltexcreting factor was probably present.
On the other hand, Lieberman and Luetscher (26) in 1960 demonstrated little or no aldosterone in the urine of six infants with salt-losing adrenal hyperplasia but normal adult amounts in normal children.
Blizzard, Liddle, Migeon, and Wilkins (27) , in a comprehensive study of normal children and children with salt-losing and simple virilizing adrenal hyperplasia, found that when salt was restricted normal children and simple virilizers showed an increase in aldosterone excretion, but salt losers did not.
Bryan, Kliman, and Bartter (28) measured aldosterone secretion and excretion in five salt losers who raised their aldosterone production only slightly when salt was restricted. The turnover rate of aldosterone ranged from 2 to 9 jg daily at base line and increased to 6 to 28 pg with salt restriction. Two normal children increased their aldosterone turnover rates from 112 and 26 to 432 and 205 ug per day, respectively, whereas salt losers increased the excretion of the 3-oxoconjugate of aldosterone to a maximum of only 2.9 ug per day with sodium deprivation.
Kowarski and co-workers (16) presented studies on two adult simple virilizers who increased their turnover rates of aldosterone from 306 and 350 to 434 and 600 jig per day. Five salt losers whose base-line secretion rates ranged from 4 to 64 did not show an increase with salt restriction. A 12-year-old boy with the hypertensive form of adrenal hyperplasia also did not increase his baseline aldosterone secretion rate with sodium restriction, which is in disagreement with the report of normal aldosterone production in a similar patient by Holub and Barlow (17) . The secretion rate of aldosterone in normal children was reported as 44 to 92 Mg per day by Kowarski (16) . Mattox (31) reported that salt losers have lower levels of aldosterone metabolites than simple virilizers and normal children of all ages.
Most recently several investigators (32-35) have reported low aldosterone secretion rates that did not increase with sodium restriction in salt losers, but normal aldosterone secretion rates in non-salt losers.
The conclusion reached by most of the research investigations (16, (26) (27) (28) (29) (31) (32) (33) (34) (35) is that an aldosterone deficiency does exist in congenital hyperplasia of the salt-losing variety, but not in the simple virilizing form.
The variation in results among different investigators may stem from an inadequacy of methods used in the earlier works. The bioassay method (23, 26, 27) and the paper visualization method (21-25, 29, 36) lack the sensitivity necessary to determine aldosterone at very low levels, and specificity of the methods usually was not adequately' evaluated (37) . Greatest reliance can be placed on those studies that properly utilized the highly sensitive and specific double dilution isotope derivative assay (1) . Studies using this technique (16, 27, 28, 31, 32) have revealed an aldosterone deficiency.
2) The sodium loss caused by ACTH in adrenal hyperplasia and in newborns may be explained by a stimulation of the adrenal glands to produce a salt-losing hormone (38) (39) (40) . Although these investigations showed that there was some increase in sodium excretion on the day after intramuscular administration of ACTH, this need not be explained by the salt-excreting factor. Where volume of urine was reported, it was always increased with increased sodium loss. The sodium diuresis after ACTH could alternatively be explained by an increased glomerular filtration rate resulting from the ACTH-induced rise in plasma cortisol (41) (42) (43) (44) (45) (46) (47) . George, Saucier, and Bartter (48) suggest the possibility that the preparations of ACTH used may have been contaminated with vasopressin, which might have induced a renal sodium loss.
Finally, the response of patients with intact adrenal glands to ACTH is by no means constant and therefore serves as a poor reference for the response of salt losers. Apparently, normal subjects may show sodium diuresis or retention after ACTH (49) (50) (51) (52) (53) . It would appear, therefore, that sodium diuresis after ACTH in salt losers is not a strong argument for the importance of the salt-excreting factor in causing salt wasting.
3) Resistance to DOC has been described in patients with adrenogenital syndrome and has been used to support the thesis that the excessive DOC is required to counteract a salt-excreting factor (SEF). The apparent resistance to DOC is based on a comparison of DOC dosages required by adults rather than by young infants. The DOC requirement of young infants, which would be a more appropriate reference, has not been clearly established. Therefore, the large DOC dosages required daily by young adrenogenital salt losers cannot be used as an argument for factors other than hypoaldosteronism as a cause of salt wasting until further data regarding DOC requirements of young infants are obtained. The patient with Addison's disease (J.Y.) was noted to have as high DOC requirement as any of the adrenogenital salt losers.
In summary, the data supporting the presence of SEF seem inconclusive at present. Attempts to isolate a salt-excreting hormone active in man have failed (54 Secretion rates of aldosterone were also measured by the same technique. When corrected for surface area, aldosterone levels of normal children and patients with simple virilizing adrenal hyperplasia are equivalent to those of adults, but are very low in children with salt-wasting adrenal hyperplasia.
Under the stress of salt restriction, salt losers cannot increase aldosterone production, but simple virilizers show a threefold increase.
The ratio of aldosterone metabolites in the urine of children is similar to that in the urine of adults.
These results support the hypothesis that aldosterone deficiency is an important factor in saltwasting adrenal hyperplasia.
